Effects of Oral Tranexamic Acid on Short Term Postoperative Outcomes Following Total Shoulder Arthroplasty

ConditionShoulder Arthroplasty

Trial statusRecruiting

Trial phasePhase 3

Trial typeInterventional

Biological sexAll

Age18-79

SponsorUniversity of Alabama at Birmingham

About this trial

The purpose of this clinical trial is to evaluate the short-term clinical outcomes of patients undergoing total shoulder arthroplasty who receive an extended postoperative course of oral tranexamic acid

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Skeletally mature patients (ages 18-79) undergoing primary total shoulder arthroplasty

Disqualifiers

Patients with Cancer, venous thromboembolism, stroke, heart disease, pregnant or nursing, allergic to TXA, current tobacco use, anticoagulants other than aspirin.

Trial design

Design model

Parallel

Treatments tested in this trial

oral tranexamic acid
Drug
one group of subjects will receive oral tranexamic acid and the other will receive oral placebo
Placebo
Drug
one group of randomized subjects will receive placebo and the other will receive oral tranexamic acid

Treatment groups

60 Participants

are divided into 2 treatment groups

Group A: oral tranexamic acidExperimental treatment 1 intervention

Group B: Oral PlaceboPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

VAS

visual analog scale

Time frame

2 weeks

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Alabama at Birmingham

Lead sponsor

Source ClinicalTrials.gov

Apply now